O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.01%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+11%)
Cap. Flow
-$84.1M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
148
New
18
Increased
32
Reduced
23
Closed
13
Top Buys
1 |
Boston Scientific
BSX
|
$234M |
2 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$105M |
3 |
Bristol-Myers Squibb
BMY
|
$77M |
4 |
BLUE
bluebird bio
BLUE
|
$66.5M |
5 |
Cardinal Health
CAH
|
$57.3M |
Top Sells
1 |
Vertex Pharmaceuticals
VRTX
|
$188M |
2 |
AGN
ALLERGAN INC
AGN
|
$158M |
3 |
Merck
MRK
|
$144M |
4 |
Biogen
BIIB
|
$122M |
5 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$106M |
Sector Composition
1 | Healthcare | 85.68% |
2 | Technology | 0.16% |
3 | Financials | 0.11% |